Moreover, CAFs also transfer miR106b to PC cells through EVs and promote gemcitabine resistance by targeting tumor protein P53 inducible nuclear protein 1 (TP53INP1) [148]. This evidence concerns the gene TP53INP1 and pachyonychia congenita.